Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01872988
Recruitment Status : Terminated (Difficult in patient enrollment)
First Posted : June 7, 2013
Last Update Posted : September 4, 2014
Gilead Sciences
Taipei Institute of Pathology
Information provided by (Responsible Party):
Chun-Ying Wu, Taichung Veterans General Hospital